FIELD: pharmacy. SUBSTANCE: invention proposes microtablets based on fumaric acid alkyl esters of the general formula (1) 
or (2) 
where A means bivalent cation; n = 1 or 2 used for treatment of patients with psoriatic arthritis, neurodermatitis, psoriasis and regional Crohn's enteritis disease. Invention allows abrupt reducing adverse effects of conventional tablets with the claimed active component with respect to digestive tract. EFFECT: enhanced medicinal properties, expanded assortment of agents of indicated designation. 10 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF ACID ALKYLFUMARATES FOR TREATMENT OF PSORIASIS, PSORIATIC ARTHRITIS, NEURODERMITIS AND CHRONIC CICATRIZING ENTERITIS (CROHN'S DISEASE) | 1998 |
|
RU2197233C2 |
| APPLICATION OF DERIVATIVES OF FUMARIC ACID IN TRANSPLANTATION MEDICINE | 1999 |
|
RU2210364C2 |
| APPLICATION OF FUMARIC ACID DERIVATIVES | 1998 |
|
RU2197963C2 |
| DERIVATIVES OF FUMARIC ACID AS NF-kappaB INHIBITOR | 2002 |
|
RU2282440C2 |
| APPLICATION OF FUMARIC ACID DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | 2000 |
|
RU2218918C1 |
| USING FUMARIC ACID DERIVATIVES FOR TREATING CARDIAC FAILURE, MYOCARDIAL INFARCTION AND ANGINA | 2007 |
|
RU2459621C2 |
| USING DERIVATIVES OF FUMARIC ACID IN TREATMENT OF CARDIAC INSUFFICIENCY AND ASTHMA | 2004 |
|
RU2313339C2 |
| FUMARIC ACID AMIDES | 2002 |
|
RU2290946C2 |
| DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
| PHARMACEUTICAL COMPOSITION, CONTAINING ONE OR MORE FUMARIC ACID ETHERS IN DEGRADABLE MATRIX | 2010 |
|
RU2552951C2 |
